Advisory

Official notices and statements regarding BF-7® authenticity, intellectual property rights, and scientific integrity.

⚠ OFFICIAL ADVISORY

Verification of BF-7® Authenticity and Intellectual Property Rights

Published: May 1, 2026

Addresses unauthorized association of products such as "Cera-Q" and "Memo-Q" with the BF-7® brand. Includes USPTO trademark cancellation decision (March 2022), FDA NDI #1041 status, MFDS individual recognition (2009-46), and 25 years of clinical research evidence.

Read full advisory →
Additional advisories will be published as Famenity continues to address matters of brand authenticity, scientific integrity, and intellectual property protection globally.
For verification requests, please contact sales@famenity.com

The global healthcare industry is undergoing a shift in its approach from focusing solely on treating diseases to emphasizing prevention and management. Famenity Co., Ltd. (formerly BrainGuard Co., Ltd.), a research and development company specializing in food and drug materials, is at the forefront of this transition

Contact

  • (16006) D 1009, 40, Imi-ro, Uiwang-si, Gyeonggi-do, Republic of Korea
  • +82-2-821-8286
  • sales@famenity.com